WILMINGTON, DE / ACCESSWIRE / December 8, 2022 / Transparency Market Research Inc. - In 2021, the India human microbiome market was worth around US$ 139.1 Mn. It is expected that the human microbiome market in India will rise at 6.9% CAGR during the forecast period, from 2022 to 2031. By 2031, the India market is likely to surpass value of US$ 282 Mn. Over the last few years, research on the human microbiome has gone from fundamental science to cutting-edge treatments. Numerous governmental organizations and pharmaceutical corporations have started a number of major studies since it became clear how important microbiome research could be for human health. This factor is expected to influence the India human microbiome modulators market in the coming years.
In India, research on the human microbiome remains in its developmental phase; considerable efforts have to be made to understand and examine the function of microbiota in determining general disease and health situations. The development of the human microbiome has been aided in recent years by the advent of novel molecular technologies including metabolomics, metagenomics, and transcriptomics. In India, there is an increase in the prevalence of several chronic inflammatory illnesses with immunological bases, including coronary artery disease, non-alcoholic fatty liver disease, diabetes, and many others. Additionally, due to people's sedentary lifestyles, various cancer types are increasing in India. The India human microbiome diagnostics market is anticipated to be driven by rising chronic disease occurrences.
Regenerative treatments and the "India Human Microbiome" have become more popular in orthopedic surgery recently. The use of amniotic cells, bone marrow aspirate, platelet-rich plasma, and adipose-derived cells has garnered keen attention.
Order a Complete Research Report on Human Microbiome Market - https://www.transparencymarketresearch.com/checkout.php?rep_id=84888<>
Key Findings of Market Report
- The probiotic segment in India is expanding steadily and has the ability to flourish significantly in the near future, as per the India human microbiome market. After a variety of pharmaceutical probiotic compositions entered the market, the segment is likely to grow.
- The use of microbiome is being driven by customers' desire for functional meals and beverages over high-calorie diets. In India, the prevalence of gastrointestinal (GI) and liver illnesses has also significantly increased, and gut microbiome research has followed. The gastrointestinal disorders category is anticipated to be driven by these factors throughout the forecast timeline.
- Research on the human gut microbiome in the Indian populace is likely to help researchers better understand how the gut microbiome varies in the presence of different illnesses and the possible consequences these changes could have on people's health. Research and development into the human gut microbiome is also anticipated to provide new insights on a variety of subjects, including dietary patterns, cultural affinities, genetics, and evolving lifestyles. The India human microbiome therapeutics market is anticipated to grow as a result of India's intensified proactive study of human gut microbiota.
Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=84888
India Human Microbiome Market: Growth Drivers
- In 2021, the highest market shares for human microbiome in India belonged to the gastrointestinal disorders category. The high incidence of certain gastrointestinal conditions and rising level of public understanding about these conditions can be attributed to the segment's development.
- Based on products and services, the product category dominated the India market for human microbiomes in 2021. The India human microbiome market is anticipated to grow due to rise in probiotic usage in the product category. It is expected to account for considerable share of human microbiome market by product. The use of specific probiotics such as bifidobacterium, lactobacillus rhamnosus, and lactobacillus acidophilus is also being driven by rising number of working women and growing focus on boosting women's health.
India Human Microbiome Market: Key Competitors
- Charles River Laboratories
- OptiBiox Health plc.
- Allianz Biosciences Pvt. Ltd. (ABPL)
- Tata Chemicals Ltd.
- QIAGEN, Inc.
- Bione Ventures Private Limited
India Human Microbiome Market: Segmentation
Product & Service
- Product
- Service
Indication
- Gastrointestinal Disorders
- Metabolic Disorders
- Women's Health Disorders
- Skin Disorders
- Others
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84888
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Rare Kidney Diseases Treatment Market: Rare Kidney Diseases Treatment Market is anticipated to reach more than US$ 4.6 Bn by the end of 2031 and to grow at a CAGR of 5.8% from 2022 to 2031.
Anti-radiation Drugs Market: Anti-radiation Drugs Market is anticipated to reach more than US$ 9.6 Bn by the end of 2031 and to grow at a CAGR of 9.9% from 2022 to 2031.
Asthma Treatment Market: Asthma Treatment Market is anticipated to reach more than US$ 34.5 Bn by the end of 2031 and to grow at a CAGR of 3.7% from 2022 to 2031.
NAMPT Inhibitors Pipeline Analysis: NAMPT inhibitors pipeline analysis to be driven by increase in research & development activities for nicotinamide phosphoribosyltransferase (NAMPT) inhibitors.
Halal and Kosher Empty Capsules Market: Halal and Kosher Empty Capsules Market is anticipated to reach more than US$ 2.9 Bn by the end of 2031 and to grow at a CAGR of 8.0% from 2022 to 2031.
Alzheimer's Disease Biomarkers Market: Alzheimer's disease biomarkers market is anticipated to reach more than US$ 1.7 Bn by the end of 2031 and to grow at a CAGR of 7.3% from 2022 to 2031.
Animal Drug Compounding Market: Animal drug compounding market is anticipated to reach more than US$ 2.4 Bn by the end of 2031 and to grow at a CAGR of 7.4% from 2022 to 2031.
Anticoagulants Market: The global anticoagulants market is anticipated to reach more than US$ 56.6 Bn by the end of 2031 at a CAGR of 6.2% from 2022 to 2031.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyse information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]
SOURCE: Transparency Market Research inc.